KNSA

Kiniksa Pharmaceuticals Internat…

48.38

-2.46-4.84%

After Hours: 48.39 +0.01 +0.02%19:58 05/29 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE47.98/47.85

TODAY RANGE47.43-50.48

VOL297.42K

MARKET CAP3.80B

52 WEEK RANGE26.27-59.87

AVG VOL (3M)693.27K

% TURNOVER0.39%

TURNOVER--

P/E (TTM)54.53

% RANGE6.38%

EPS(TTM)0.9067

P/E(FORWARD)40.52

P/B6.28

BVPS7.87

DIVIDEND--

P/S5.57

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP2.20B

SHARES OUTSTANDING76.94M

NEXT EARNINGS07/27-07/31

FREE FLOAT44.46M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

TipRanks·5d ago
Kiniksa Shareholders Reelect Directors and Approve Auditor Mandates
PUBT·5d ago
Kiniksa Pharmaceuticals held annual shareholder meeting
TipRanks·05/26 22:09
Kiniksa Pharmaceuticals Caps Major Shareholder Voting Control Rights
PUBT·05/26 20:55
Kiniksa shareholders waive share conversion rights above 49.9% voting stake
PUBT·05/08 17:30
Kiniksa Pharmaceuticals announces annual shareholder meeting
PUBT·05/08 17:30
Kiniksa publishes 2025 annual report
Simply Wall St·05/06 03:30
Why Kiniksa Pharmaceuticals (KNSA) Is Up 5.4% After Raising 2026 Revenue Guidance And What's Next
PUBT·05/05 21:15
Kiniksa CMO John F. Paolini disposes 58,424 shares for $3.15 million
Simply Wall St·05/05 01:33
Assessing Kiniksa Pharmaceuticals (KNSA) Valuation After Strong Q1 Results And Raised Revenue Guidance
TipRanks·05/04 12:22
Analysts Are Bullish on These Healthcare Stocks: Kiniksa Pharmaceuticals (KNSA), Kymera Therapeutics (KYMR)
TipRanks·05/01 21:55
Kiniksa Pharmaceuticals CSO Resigns and Shifts to Advisor
PUBT·05/01 20:34
Kiniksa Chief Strategy Officer Eben Tessari resigns to pursue new role
PUBT·05/01 20:33
Kiniksa CEO Sanj K Patel sells shares worth $2.62 million
PUBT·04/30 22:33
Kiniksa CEO Sanj K Patel disposes of 486,339 shares for $25.23 million
Simply Wall St·04/30 15:12
Is It Too Late To Consider Kiniksa Pharmaceuticals (KNSA) After Its 91% One-Year Surge?

Same Industry

Name/Symbol

Change%

Price

Kiniksa Pharmaceuticals International, plc

KNSA

-4.84%

48.38

MCK

BIIB

AMGN

SHPG

CELG-RT

Lilly Eli & Co

LLY

-1.93%

Celgene

CELG

0.00%

108.24

Therapeuticsmd Inc

TXMD

+1.42%

2.140

Johnson & Johnson

JNJ

+0.60%

224.24

Abbvie Inc

ABBV

-0.42%

217.72

Zoetis Inc

ZTS

+1.97%

77.90

Gilead Sciences Inc

GILD

-1.31%

134.43

Novo-Nordisk A/S

NVO

+0.15%

45.58

Bristol-Myers Squibb Co

BMY

-0.89%

54.46

ALXN

Pfizer

PFE

+0.15%

26.18

Sanofi FR

SNY

-1.40%

43.67

GCVRZ

NVS

Dr Reddys Labs

RDY

-1.73%

13.03

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.